Review
Open access
Jul 2026
The role of serologic biomarkers “liquid biopsy” in the fight against breast cancer: From biological foundations to clinical impact
Overall, liquid biopsy is transitioning from a complementary diagnostic tool toward a longitudinal framework for cancer management, although substantial methodological and systemic challenges remain.
Yan Li, Yi Wang, Rong Wang et al.
· iScience · 1 citation